Dupont Capital Management’s Medicines Co MDCO Stock Holding History

Dupont Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,300	Closed	-$1.72M	–	1454
2019 Q4	$1.72M	Buy	+20,300	New	+$1.35M	0.04%	391
2014 Q1	–	Sell	-43,337	Closed	-$1.67M	–	670
2013 Q4	$1.67M	Buy	43,337 +28,757	+197%	+$1.03M	0.03%	398
2013 Q3	$489K	Buy	+14,580	New	+$464K	0.01%	555

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Dupont Capital Management's MDCO Position: Q1 2020 in Review

Dupont Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 20,300 shares — an estimated $1.72M sold.

Dupont Capital Management first reported a position in MDCO in Q3 2013 and held it in 3 quarters. The position peaked at $1.72M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Dupont Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Dupont Capital Management sold 20,300 Medicines Co shares in Q1 2020, an estimated $1.72M.
Dupont Capital Management first reported a position in Medicines Co in Q3 2013 and held it in 3 quarters.
Dupont Capital Management's Medicines Co position peaked at $1.72M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Dupont Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.